We are delighted to congratulate Professor Alwin Krämer, Principal Investigator in CRC 1709, on being awarded the prestigious Paul Martini Prize 2026. The award recognizes Professor Krämer’s pioneering work in the field of Cancer of Unknown Primary (CUP). He led…
Understanding and overcoming therapy resistance remains one of the central challenges in cancer research. A publication by Cornelius Pauli (A02 project) in Blood contributes important insights into this question. Therapy resistance in acute myeloid leukemia (AML) remains a major clinical…
As part of the CRC1709 Invited Speaker Series, we are pleased to welcome Prof. Jérôme Tamburini from the Geneva University Hospitals (HUG) and the University of Geneva. In his upcoming seminar titled Iron metabolism as a central driver of stem…
